The flu, also known as influenza, is a contagious respiratory illness caused by viruses
that infect the nose, throat, and sometimes the lungs.
Flu Vaccine Clinical Trials
In pursuit of advancing influenza prevention methods, our organization embarked on a Phase 3 clinical trial aimed at evaluating the efficacy and safety of a groundbreaking flu vaccine. What sets this vaccine apart is its utilization of modRNA technology, representing a significant departure from traditional flu shot formulations.
Our motivation behind this trial was rooted in a desire to comprehensively assess the vaccine’s effectiveness in preventing influenza infections, particularly in comparison to the established standard of care provided by conventional flu vaccines. Through meticulous research and rigorous testing, we sought to ascertain whether this innovative approach to vaccination could offer a comparable level of protection against flu viruses, thus potentially revolutionizing influenza prevention strategies.
Current Status
Total Studies
Enrollment Process
Clinical trials are essential for advancing medical knowledge and improving patient care by testing the efficacy and safety of potential treatments before they are widely available to the public. Here’s what you can expect when considering enrollment.
Recruitment
Recruiting volunteers is the first step of an active clinical trial.
Phone Screening
You will undergo a phone screening to determine your eligibility.
Informed Consent
You must sign an ICF defining the purpose, procedure, potential risks & benefits, and your rights as participants.